These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16886615)

  • 1. Preliminary study of chemosenstivity tests in osteosarcoma using a histoculture drug response assay.
    Lee SY; Jeon DG; Cho WH; Song WS; Kim MB; Park JH
    Anticancer Res; 2006; 26(4B):2929-32. PubMed ID: 16886615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro chemosensitivity assay for human osteosarcoma using tumor xenografts.
    Fujisaki T; Wada T; Takahashi M; Yamawaki S; Ishii S
    Clin Orthop Relat Res; 1995 Apr; (313):279-85. PubMed ID: 7641491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cytotoxic treatment of patients with osteosarcoma by an in vitro chemoresistance assay.
    Agiostratidou G; Demertzis N; Gonos ES
    Anticancer Res; 2000; 20(5B):3603-8. PubMed ID: 11131668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of chemotherapy based on an in vitro chemosensitivity test in urothelial cancer patients.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Anticancer Res; 2001; 21(6A):4061-6. PubMed ID: 11911292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor chemosensitivity differs between clinical sarcoma and adenocarcinoma tissues.
    Takeuchi H; Baba H; Inutsuka S; Takahashi I; Kusumoto H; Maehara Y; Sugimachi K
    Anticancer Res; 1994; 14(1A):169-71. PubMed ID: 8166444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
    Kwon YE; Park JY; Kim WK
    Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer].
    Tanahashi M; Yamada T; Moriyama S; Suzuki E; Niwa H
    Kyobu Geka; 2008 Jan; 61(1):26-30. PubMed ID: 18186269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of histoculture drug response assays in colorectal cancer chemotherapy.
    Yoon YS; Kim CW; Roh SA; Cho DH; Kim GP; Hong YS; Kim TW; Kim MB; Kim JC
    Anticancer Res; 2012 Aug; 32(8):3581-6. PubMed ID: 22843949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents.
    Suda S; Akiyama S; Sekiguchi H; Kasai Y; Ito K; Nakao A
    Surg Today; 2002; 32(6):477-81. PubMed ID: 12107769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro chemosensitivity of human soft tissue sarcoma.
    Morioka H; Yabe H; Morii T; Yamada R; Kato S; Yuasa S; Yano T
    Anticancer Res; 2001; 21(6A):4147-51. PubMed ID: 11911309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
    Chen W; Zhou X; Xu Q; Guo W; Lin L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
    Tomita K; Tsuchiya H; Sasaki T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):576-84. PubMed ID: 2705788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
    Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
    Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
    Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
    Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human tumor clonogenic assay in osteosarcoma and its clinical evaluation].
    Tomita K; Yokogawa A; Nomura S
    Gan To Kagaku Ryoho; 1986 May; 13(5):1876-80. PubMed ID: 3458429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.